Kristyna Kupcova

Prague, PR, Czech Republic

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Noble metal/dextran-graft-polyacrylamide branched polymer nanocomposites induce ROS-dependent apoptosis in diffuse large B-cell lymphoma cells.

Noble metal/dextran-graft-polyacrylamide branched polymer nanocomposites induce ROS-dependent apoptosis in diffuse large B-cell lymphoma cells.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: November 13, 2025

Inhibition of autoantigen-induced B-cell receptor (BCR) internalization as a therapeutic strategy in diffuse large B cell lymphoma (DLBCL).

Inhibition of autoantigen-induced B-cell receptor (BCR) internalization as a therapeutic strategy in diffuse large B cell lymphoma (DLBCL).

Journal: Cell death & disease

Published: July 31, 2025

Circulating tumour DNA as a predictor of survival of patients with diffuse large B-cell lymphoma in a daily practice.

Circulating tumour DNA as a predictor of survival of patients with diffuse large B-cell lymphoma in a daily practice.

Journal: British journal of haematology

Published: May 29, 2025

Circulating tumor DNA as a powerful tool in diagnostics and treatment outcome prediction - focus on large B-cell lymphomas and follicular lymphomas.

Circulating tumor DNA as a powerful tool in diagnostics and treatment outcome prediction - focus on large B-cell lymphomas and follicular lymphomas.

Journal: Expert review of molecular diagnostics

Published: May 06, 2025

Development and Technical Validation of the Clinical Lymphoma Exploration and Research Sequencing (CLEARS) Panel and Its Optimization for ctDNA Analysis.

Development and Technical Validation of the Clinical Lymphoma Exploration and Research Sequencing (CLEARS) Panel and Its Optimization for ctDNA Analysis.

Journal: Folia biologica

Published: January 01, 2025

Immune Checkpoints and Their Inhibition in T-Cell Lymphomas.

Immune Checkpoints and Their Inhibition in T-Cell Lymphomas.

Journal: Folia biologica

Published: December 07, 2024

Long-term adaptation of lymphoma cell lines to hypoxia is mediated by diverse molecular mechanisms that are targetable with specific inhibitors.

Long-term adaptation of lymphoma cell lines to hypoxia is mediated by diverse molecular mechanisms that are targetable with specific inhibitors.

Journal: Cell death discovery

Published: August 05, 2024

Vertical targeting of the PI3K/AKT pathway at multiple points is synergistic and effective for non-Hodgkin lymphoma.

Vertical targeting of the PI3K/AKT pathway at multiple points is synergistic and effective for non-Hodgkin lymphoma.

Journal: Experimental hematology & oncology

Published: June 27, 2024

Impact of PIK3CA gain and PTEN loss on mantle cell lymphoma biology and sensitivity to targeted therapies.

Impact of PIK3CA gain and PTEN loss on mantle cell lymphoma biology and sensitivity to targeted therapies.

Journal: Blood advances

Published: March 22, 2024

B-Cell Receptor Signaling and Beyond: The Role of Igα (CD79a)/Igβ (CD79b) in Normal and Malignant B Cells.

B-Cell Receptor Signaling and Beyond: The Role of Igα (CD79a)/Igβ (CD79b) in Normal and Malignant B Cells.

Journal: International journal of molecular sciences

Published: November 13, 2023

Cyclin dependent kinase 4/6 inhibitor palbociclib synergizes with BCL2 inhibitor venetoclax in experimental models of mantle cell lymphoma without RB1 deletion.

Cyclin dependent kinase 4/6 inhibitor palbociclib synergizes with BCL2 inhibitor venetoclax in experimental models of mantle cell lymphoma without RB1 deletion.

Journal: Experimental hematology & oncology

Published: September 01, 2023

Antigen-independent, autonomous B cell receptor signaling drives activated B cell DLBCL.

Antigen-independent, autonomous B cell receptor signaling drives activated B cell DLBCL.

Journal: The Journal of experimental medicine

Published: May 31, 2023

Showing 1-12 of 18

Last Updated: 09/26/2026